Gregory Scott Duncan
CHIEF EXECUTIVE OFFICER · Dogwood Therapeutics, Inc.
Individual
- 2025
- Mar 6, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gregory Scott Duncan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Janet Dillione - $1.55M in CRMD purchases and sales in the last 12 months
- Steven W. Lefkowitz - $475K in CRMD purchases and sales in the last 12 months
- Joseph Todisco - $360K in CRMD purchases and sales in the last 12 months
- Alan W. Dunton - $260K in CRMD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gregory Scott Duncan?
Gregory Scott Duncan is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER of Dogwood Therapeutics, Inc. (DWTX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Gregory Scott Duncan last file a Form 4?
The most recent primary Form 4 on record is dated 6 March 2026, one of 5 filings going back to 2025.
